Drug allergy screening: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{CMG}} {{AE}} {{CP}} ==Overview== Screening options for drug allergies are limited. This is mainly because drug allergies fall under the type B unpredictable drug...")
 
No edit summary
Line 2: Line 2:


{{CMG}} {{AE}} {{CP}}
{{CMG}} {{AE}} {{CP}}
{{Drug allergy}}


==Overview==
==Overview==
Screening options for drug allergies are limited. This is mainly because drug allergies fall under the type B unpredictable drug reactions that occur only in susceptible individuals. To screen for drug allergy, one would have to be exposed to the drug, which may mean putting the individual at an uneccesary risk for a severe drug reaction through a screening test.
Screening options for drug allergies are limited. This is mainly because drug allergies fall under the type B unpredictable type drug reactions that occur only in susceptible individuals. To screen for drug allergy, one would have to be exposed to the drug, which may mean putting the individual at an uneccesary risk for a severe drug reaction through a [[screening]] test.
 
==Screening for Drug Allergy in Specific Circumstances==
* [[Skin prick testing]] (SPT) and intradermal testing (a test where a small amount of allergen is injected into the dermal layer of the skin) are useful for predicting an allergic reaction mediated by IgE-mediated reactions. Skin testing protocols are standardized for drugs such as penecillin, and are also useful (but rarely positive) for locall anesthetics, muscle relaxants, and very sensitive for high-molecular-weight protein substances such as insulin and monoclonal antibodies.

Revision as of 13:27, 20 August 2012


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]

Drug Allergy

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Drug allergy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Drug allergy screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Drug allergy screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Drug allergy screening

CDC on Drug allergy screening

Drug allergy screening in the news

Blogs on Drug allergy screening

Directions to Hospitals Treating Drug allergy

Risk calculators and risk factors for Drug allergy screening

Overview

Screening options for drug allergies are limited. This is mainly because drug allergies fall under the type B unpredictable type drug reactions that occur only in susceptible individuals. To screen for drug allergy, one would have to be exposed to the drug, which may mean putting the individual at an uneccesary risk for a severe drug reaction through a screening test.

Screening for Drug Allergy in Specific Circumstances

  • Skin prick testing (SPT) and intradermal testing (a test where a small amount of allergen is injected into the dermal layer of the skin) are useful for predicting an allergic reaction mediated by IgE-mediated reactions. Skin testing protocols are standardized for drugs such as penecillin, and are also useful (but rarely positive) for locall anesthetics, muscle relaxants, and very sensitive for high-molecular-weight protein substances such as insulin and monoclonal antibodies.